Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ephedrine sulfate 15 mg and theophylline 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Ephedrine sulfate 15 mg and theophylline 120 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 11 mg and theophylline 120 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Ephedrine sulfate 15 mg and theophylline 120 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Theophylline (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Theophylline (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Theophylline (substance) |
Inferred relationship |
Some |
2 |
Theophylline sodium acetate (substance) |
Is a |
False |
Theophylline (substance) |
Inferred relationship |
Some |
|
Theophylline anhydrous |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
|
Theophylline sodium glycinate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
|
Theophylline sodium acetate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
|
Theophylline monohydrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
|
Theophylline calcium salicylate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
|
Choline theophyllinate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
|
Theophylline 500mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Some |
|
Theophylline 50mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Some |
|
Theophylline 65mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Some |
|
Theophylline 130mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Some |
|
Theophylline 260mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Some |
|
Theophylline 100mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Some |
|
Theophylline 2 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Some |
|
Product containing precisely theophylline 250 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline 250 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline 175 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline 175 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline 300 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline 300 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline 200 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline 200 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline 300 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline 300 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline 125 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline 125 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline 250 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline 250 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Ephedrine sulfate 15 mg and theophylline 120 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Theophylline (substance) |
Inferred relationship |
Some |
2 |
Theophylline 125 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline 300 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 11 mg and theophylline 120 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing ephedrine and theophylline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline 75 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline 250 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Theophylline (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Theophylline (substance) |
Inferred relationship |
Some |
2 |
Guaifenesin- and theophylline-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing only ephedrine and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing only guaifenesin and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing only potassium iodide and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing only theophylline in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Ephedrine and theophylline only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing only guaifenesin and theophylline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing only theophylline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline 2 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline 2 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline 5.33 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline 5.33 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline (as theophylline sodium glycinate) 11 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Ephedrine sulfate 15 mg and theophylline 120 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing salbutamol and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing only salbutamol and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Salbutamol and theophylline only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing salbutamol and theophylline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing etofylline and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Etofylline and theophylline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing etofylline and theophylline in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing only etofylline and theophylline in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Product containing only etofylline and theophylline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Etofylline- and theophylline-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Plasma theophylline level (procedure) |
Component |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Serum theophylline level (procedure) |
Component |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline measurement, saliva |
Component |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |
Theophylline measurement, blood |
Component |
True |
Theophylline (substance) |
Inferred relationship |
Some |
1 |